Recorded Chinese product: 托吡卡胺滴眼液托吡卡胺滴眼液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 无锡济民可信山禾药业股份有限公司Chinese legal name: 无锡济民可信山禾药业股份有限公司
主要成分Active Ingredients
- 托吡卡胺Tuobi Kaan
药物知识说明
托吡卡胺是一种在国家药监局注册认定的药品。该药品含有托吡卡胺-578bf852等成分。
该药品关联的活性成分包括：托吡卡胺Tuobi Kaan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：无锡济民可信山禾药业股份有限公司Chinese legal name: 无锡济民可信山禾药业股份有限公司。
您可以探索含有相同成分的其他药品：托吡卡胺-578bf852成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 托吡卡胺滴眼液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 托吡卡胺Tuobi Kaan.
Manufacturers recorded for this product: 无锡济民可信山禾药业股份有限公司Chinese legal name: 无锡济民可信山禾药业股份有限公司.
Explore other medicines containing the same ingredient: 托吡卡胺 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 托吡卡胺滴眼液Recorded Chinese product: 托吡卡胺滴眼液
- 剂型Dosage form: 滴眼剂Eye drops
- 规格Specification: 6ml:15mg6 mL:15 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 无锡济民可信山禾药业股份有限公司Chinese legal name: 无锡济民可信山禾药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32021199
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32021199
Manufacturer
Chinese legal name: 无锡济民可信山禾药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H32021199
生产企业
无锡济民可信山禾药业股份有限公司(国产)
适应症
用于滴眼散瞳和调节麻痹。
用法用量
滴眼剂0.5%～1%溶液滴眼，一次一滴，间隔5分钟滴第二次。
不良反应
本品0.5%溶液滴眼1～2次，每次一滴的不良反应罕见，1%溶液可能产生暂时的刺激症状。本品为散瞳药，故在散瞳期间视物稍有不便，5小时即可恢复眼的正常调节功能。因本品为类似阿托品的药物，故可使闭角型青光眼眼压急剧升高，也可能激发未被诊断的闭角型青光眼。
禁忌
闭角型青光眼者禁用；婴幼儿有脑损伤、痉挛性麻痹及先天愚型综合征者反应强烈应禁用
注意事项
1.为避免药物经鼻粘膜吸收，滴眼后应压迫泪囊部2～3分钟。2.如出现口干、颜面潮红等阿托品样毒性反应应即停用，必要时予拟胆碱类药物解毒。3.出现眼压升高及过敏症状时应停用。
贮藏
阴凉干燥处保存
规格
6ml:15mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.